The BC Diabetes Research Network is delighted to announce the launch of our official podcast: “Diabetes: From Beta Cells to Bicycles“. In our first season, host Krista Lamb sits down with six prominent diabetes researchers in British Columbia, discussing the many aspects of diabetes research and the exciting work being done in the province. “Diabetes: From Beta Cells to Bicycles” refers to the…
Read More

New Molecule Could Enhance the Efficacy of Childhood Cancer Treatments

Researchers are investigating a therapy that could reduce the long-term side effects of interventions for childhood solid tumours. While rare, childhood cancer is the leading disease-related cause of death among Canadian children1,  and affects approximately 1,000 children under the age of 15 each year2. Translational cancer research being conducted at the Vancouver Prostate Centre is investigating a therapy for childhood…
Read More
Chinook Therapeutics, Inc., a biotechnology company focused on developing precision medicines for kidney diseases, today announced it has entered into a license agreement with AbbVie, a research-based global biopharmaceutical company, for worldwide, exclusive rights to atrasentan, an endothelin receptor antagonist. Chinook will assume all development and commercialization responsibilities for atrasentan globally. Chinook plans to initiate a clinical trial of atrasentan…
Read More
Read the Publication This week we profile a recent publication in eLife from Dr. Parisa Asghari (pictured) the laboratory of Dr. Edwin Moore at UBC. Can you provide a brief overview of your lab’s current research focus? The Moore lab is studying the mechanisms which control excitation-contraction coupling in muscle cells. What is the significance of the findings in this publication? Dysfunctional…
Read More
Twenty-six research excellence clusters led by researchers on the Vancouver campus will be funded through the Research Excellence Clusters initiative in 2020/21. These clusters are inter-departmental networks of researchers at UBC who collectively represent leaders in a particular field of study. Clusters are recognized as either established or emerging depending on multiple factors relating to their developmental stage and funding…
Read More

New Research Identifies Third Gene Behind Rare Overgrowth Syndrome in Children

When Ali’s son Howard* was still not crawling, rolling over or meeting her gaze at 10 months old, the experienced mother-of-two knew something was wrong. Despite assurances from friends and family that everything was fine, Ali brought it up with her family doctor. After rounds of tests and specialist appointments, an MRI scan revealed damaged tissue in the area of…
Read More
Chronic pain is a common and often debilitating problem that can significantly impact function and quality of life for patients with spinal cord injury. To help find treatment solutions, UBC researchers are investigating the effectiveness of a drug called Targin at treating chronic pain in individuals with spinal cord injury. The research team is now recruiting study participants. Dr. Andrei Krassioukov…
Read More
Congratulations to Dr. Ly Vu who has been awarded a three-year Basic/Translational Fellow to Faculty Award from the American Society of Hematology. Dr. Vu received funding of $125,000 USD for her research, “Uncovering the Role of CNOT poly(A) deadenylation in Acute Myeloid Leukemia.” The American Society of Hematology (ASH) recognized 39 recipients for the 2020 Scholar Awards. One of ASH’s…
Read More
Although Centre for Blood Research (CBR) member Daniel Luo describes himself as a “typical 25-year old who plays games, reads books, listens to podcasts and socializes at the pub”, his passion for research, work ethic on committees, and optimistic mindset is anything but ordinary. As a PhD student in the Kizhakkedathu Lab, Daniel has made the most of some amazing opportunities. In…
Read More
With a shared vision to be a catalyst for Canadian life sciences leading the world, adMare BioInnovations, Canada’s Global Life Sciences Venture (adMare), and Accel-Rx, Canada’s Health Sciences Accelerator (Accel-Rx), announced today they are bringing their respective capabilities and resources together under adMare to create a world leading organization. The combined efforts will be guided by adMare’s Board of Directors,…
Read More